VAERS Explorer
Back to explore

Report #2870312

Received Nov 3, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
IL
Recovered
Not recovered
Vaccinated
Oct 20, 2025
Onset
Oct 20, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
TDAPTDAP (BOOSTRIX)GLAXOSMITHKLINE BIOLOGICALSUNK94KG2—

Symptoms (1)

Photophobia

Symptom narrative

Light sensitivity to eye; This non-serious case was reported by a other health professional and described the occurrence of photophobia in a 33-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number 94KG2, expiry date 28-NOV-2027) for prophylaxis. On 20-OCT-2025, the patient received Boostrix .5 ml. On 20-OCT-2025, an unknown time after receiving Boostrix, the patient experienced photophobia (Verbatim: Light sensitivity to eye). The outcome of the photophobia was resolving. It was unknown if the reporter considered the photophobia to be related to Boostrix. It was unknown if the company considered the photophobia to be related to Boostrix. Additional Information: GSK Receipt Date: 21-OCT-2025 The reporter mentioned that patient developed light sensitivity to eye after the Boostrix vaccine. The batch number was not provided and a request for this information has been made.